Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

Clinical trial NCT07011810 · RECRUITING

Trial details

NCT number: NCT07011810
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Graft Versus Host Disease

Start date: 2025-08-06
Primary completion: 2028-08-10
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.